Ann ConkleApr 4, 2012Stemline Therapeutics announces IPO0 CommentsCancer therapy that zeroes in on stem cells seeks $50 million IPOThe company developing cancer therapies to destroy cancer stem cells to treat brain cancer and acute myeloid leukemia is seeking to raise $50 million in an IPO. Read more.